Utah Medical Products, Inc.UTMDNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | 34.98% |
| Q2 2025 | -35.64% |
| Q1 2025 | 51.99% |
| Q4 2024 | -23.83% |
| Q3 2024 | 39.61% |
| Q2 2024 | -47.65% |
| Q1 2024 | -1.05% |
| Q4 2023 | 4.12% |
| Q3 2023 | 4.23% |
| Q2 2023 | -28.95% |
| Q1 2023 | 21.74% |
| Q4 2022 | 1.63% |
| Q3 2022 | 15.67% |
| Q2 2022 | -4.24% |
| Q1 2022 | 1.18% |
| Q4 2021 | -16.76% |
| Q3 2021 | 27.69% |
| Q2 2021 | -15.20% |
| Q1 2021 | -4.24% |
| Q4 2020 | 15.38% |
| Q3 2020 | 36.20% |
| Q2 2020 | -35.20% |
| Q1 2020 | 0.59% |
| Q4 2019 | -11.47% |
| Q3 2019 | 278.61% |
| Q2 2019 | -49.91% |
| Q1 2019 | -25.05% |
| Q4 2018 | -2.63% |
| Q3 2018 | 15.65% |
| Q2 2018 | 5.71% |
| Q1 2018 | -17.86% |
| Q4 2017 | 0.09% |
| Q3 2017 | 33.36% |
| Q2 2017 | -20.25% |
| Q1 2017 | 25.86% |
| Q4 2016 | 1.33% |
| Q3 2016 | -6.09% |
| Q2 2016 | -12.99% |
| Q1 2016 | 5.81% |